Byotrol Regulatory News (BYOT)

Byotrol plc

("Byotrol" or the "Company")

Board Appointment

Byotrol plc (AIM: BYOT), the specialist infection prevention and control company is pleased to announce the appointment of Ashley Head to the Board as an independent Non-Executive Director, with effect from our AGM on 13 September 2023.

Ashley began his career with Chase Manhattan Bank, where he rose through the ranks of technology and online banking. He then joined MasterCard, where he became responsible for the African region of the group. After recognising the opportunities within eCommerce Ashley founded Proc Cyber, growing the business to a valuation of over £60 million in three years and then merging with Datacash in 2006 where he assumed the role of Chairman. Under Ashley's leadership, Datacash grew to a market leading position with MasterCard purchasing the company in 2010. Ashley continues to lead a vibrant portfolio career and currently serves as Chairman of The AI Corporation, MySense Group and Champagne Piaff in addition to other director positions. He is also a trustee for the National Emergency Trust, Epsom College and Stonegate Foundation.

Commenting, Trevor Francis, Chairman, said:

"When John Langlands retired we committed as a Board to appoint another Non-Executive Director, especially with small cap public market experience. I am delighted that Ashley Head has now agreed to join the Board and will now be bringing his significant experience and commercial acumen to our Company. We welcome Ashley to the team and we look forward to working with him in our determination to drive the business forward and to capitalise on the continuing and substantial opportunities in infection control markets".

For further information, visit www.byotrolplc.com, follow on twitter @byotrol, or contact

Notes to Editors:

 Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

For more information, go to byotrol.com

Regulatory disclosures

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Ashley John Head, aged 72:

Ashley Head holds or has held the following directorships/partnerships in the past five years:

Ashley has a beneficial interest in 7,696,755 ordinary shares of the Company, representing 1.70 per cent. of the total issued share capital.

The Company confirms that there are no other disclosures to be made pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies with respect to Ashley Head.